Alzheimer’s disease (AD) is a progressive, neurodegenerative disease characterized by accumulation of beta-amyloid in extracellular plaques and tau protein in intracellular neurofibrillary tangles ...

Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s essential for ...

In October, Caring—an organization supporting caregivers of people with dementia—released its rankings of the most dementia-friendly states. Such reports are issued occasionally by various entities, ...

Researchers at UMass Lowell have uncovered an innovative way to spot Alzheimer’s disease long before the first official ...

The researchers have possibly figured out how to combat one of the early signs of the neurodegenerative disease.

As we continue to navigate the complexities of aging, the Office of the Seniors Advocate is stepping up its game in 2026.

As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be some of the most distressing aspects for caregivers and loved ones.

Are you interested in lowering your risk of developing Alzheimer’s disease and other types of dementia? We can take actions ...

What began as a surprising experiment with cell phone-like signals has led to a promising new approach to treating Alzheimer’s disease. Follow the decades-long research journey behind a head cap ...

Highlights from CTAD 2025 include GLP-1 agonist data, p-tau217 biomarker utility, subcutaneous lecanemab trials, and racial disparities in trial enrollment.

Chronic traumatic encephalopathy has long been discussed as a possible driver of dementia, but proving that link has been ...